Literature DB >> 18622594

The development of microalbuminuria is associated with raised longitudinal adiponectin levels in female but not male adolescent patients with type 1 diabetes.

R Amin1, J Frystyk, K Ong, R N Dalton, A Flyvbjerg, D B Dunger.   

Abstract

AIMS/HYPOTHESIS: We determined the longitudinal relationship between adiponectin levels and the development of microalbuminuria in an inception cohort of children with type 1 diabetes.
METHODS: Blood samples collected annually over a median of 9.0 (range 1.3-14.9) years were assayed for adiponectin and HbA(1c) in 55 children (36 girls) with type 1 diabetes and microalbuminuria whose age of onset of diabetes was 9.4 years (range 2.2-15.4). Samples were also assayed from normoalbuminuric children (controls) matched for age, sex and duration of diabetes.
RESULTS: Overall, adiponectin levels were higher in girls than in boys, but only after 11 years of age (median [range]: 15.3 [5.8-124.4] vs 11.6 [4.1-26.5] mg/l, p < 0.001). Furthermore, adiponectin levels were higher in girls with microalbuminuria than in control girls, but this was only apparent after the onset of microalbuminuria (p = 0.001, adjusted for BMI, daily insulin dose, HbA(1c) and age). In boys, adiponectin levels did not differ between those with microalbuminuria and controls. Further sex-related discordant associations with adiponectin levels were observed; in girls, adiponectin levels were positively related to HbA(1c) levels (r = 0.2, p = 0.05) and urine albumin excretion (r = 0.3, p < 0.05) and inversely related to BMI (r = -0.2, p < 0.05). These associations were absent in boys. CONCLUSIONS/
INTERPRETATION: In adolescent girls with type 1 diabetes but not in boys, adiponectin levels increase with increasing urine albumin excretion and onset of microalbuminuria. Although causal links cannot be inferred, this sexual dimorphism may reflect interactive effects of hyperglycaemia and sex steroids on risk of complications and adiponectin production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622594     DOI: 10.1007/s00125-008-1081-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  34 in total

1.  Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats.

Authors:  Peter M Thulé; Adam G Campbell; Dean J Kleinhenz; Darin E Olson; Joshua J Boutwell; Roy L Sutliff; C Michael Hart
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-08-23       Impact factor: 4.310

2.  Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

Authors:  Mélanie Côté; Pascale Mauriège; Jean Bergeron; Natalie Alméras; Angelo Tremblay; Isabelle Lemieux; Jean-Pierre Després
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

3.  Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.

Authors:  Norbert Stefan; Barbora Vozarova; Tohru Funahashi; Yuji Matsuzawa; Christian Weyer; Robert S Lindsay; Jack F Youngren; Peter J Havel; Richard E Pratley; Clifton Bogardus; P Antonio Tataranni
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

4.  The LMS method for constructing normalized growth standards.

Authors:  T J Cole
Journal:  Eur J Clin Nutr       Date:  1990-01       Impact factor: 4.016

5.  Insulin resistance in insulin-dependent diabetic patients with microalbuminuria.

Authors:  J Yip; M B Mattock; A Morocutti; M Sethi; R Trevisan; G Viberti
Journal:  Lancet       Date:  1993-10-09       Impact factor: 79.321

6.  Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus.

Authors:  Toshimitsu Yatagai; Shoichiro Nagasaka; Ataru Taniguchi; Mitsuo Fukushima; Tomoatsu Nakamura; Akira Kuroe; Yoshikatsu Nakai; Shun Ishibashi
Journal:  Metabolism       Date:  2003-10       Impact factor: 8.694

7.  Determinants of serum adiponectin in persons with and without type 1 diabetes.

Authors:  David M Maahs; Lorraine G Ogden; Janet K Snell-Bergeon; Gregory L Kinney; R Paul Wadwa; John E Hokanson; Dana Dabelea; Adam Kretowski; Robert H Eckel; Marian Rewers
Journal:  Am J Epidemiol       Date:  2007-06-24       Impact factor: 4.897

8.  Adiponectin is independently associated with glycosylated haemoglobin.

Authors:  José Manuel Fernández-Real; Patricia Botas-Cervero; Abel López-Bermano; Roser Casamitjana; Tohru Funahashi; Elías Delgado; Shinji Kihara; Wifredo Ricart
Journal:  Eur J Endocrinol       Date:  2004-02       Impact factor: 6.664

9.  Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications.

Authors:  Ayanthi A Richards; Tim Stephens; Hayley K Charlton; Alun Jones; Graeme A Macdonald; Johannes B Prins; Jonathan P Whitehead
Journal:  Mol Endocrinol       Date:  2006-02-23

10.  Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

Authors:  Hironori Waki; Toshimasa Yamauchi; Junji Kamon; Yusuke Ito; Shoko Uchida; Shunbun Kita; Kazuo Hara; Yusuke Hada; Francis Vasseur; Philippe Froguel; Satoshi Kimura; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2003-07-23       Impact factor: 5.157

View more
  5 in total

1.  Adiponectin levels in people with Latent Autoimmune Diabetes-a case control study.

Authors:  Sinead Brophy; Helen Davies; Jeffrey W Stephens; Sarah L Prior; Mark Atkinson; Stephen Bain; Rhys Williams
Journal:  BMC Res Notes       Date:  2010-11-22

2.  Urinary adiponectin concentration is positively associated with micro- and macro-vascular complications.

Authors:  Won Seon Jeon; Ji Woo Park; Namseok Lee; Se Eun Park; Eun Jung Rhee; Won Young Lee; Ki Won Oh; Sung Woo Park; Cheol-Young Park; Byung-Soo Youn
Journal:  Cardiovasc Diabetol       Date:  2013-09-28       Impact factor: 9.951

3.  Effect of early glycemic control on HbA1c tracking and development of vascular complications after 5 years of childhood onset type 1 diabetes: Systematic review and meta-analysis.

Authors:  Veena Mazarello Paes; Jessica K Barrett; David C Taylor-Robinson; Heather Chesters; Dimitrios Charalampopoulos; David B Dunger; Russell M Viner; Terence J Stephenson
Journal:  Pediatr Diabetes       Date:  2019-04-24       Impact factor: 4.866

4.  Treatment-Induced Changes in Plasma Adiponectin Do Not Reduce Urinary Albumin Excretion in the Diabetes Prevention Program Cohort.

Authors:  Kieren J Mather; Qing Pan; William C Knowler; Tohru Funahashi; George A Bray; Richard Arakaki; Bonita Falkner; Kumar Sharma; Barry J Goldstein
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

5.  Longitudinal Analysis of Adiponectin through 20-Year Type 1 Diabetes Duration.

Authors:  Tamara J LeCaire; Mari Palta
Journal:  J Diabetes Res       Date:  2015-04-09       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.